Growth factor use and rate of neutropenic complications in breast cancer patients treated with dose-dense paclitaxel: A 5-year experience from a safety net hospital.

Racha Halawi,Kavi Patel,Ethan Tobias,Samira Syed,Nisha Unni,Hsiao Ching Li,Navid Sadeghi

Growth factor use and rate of neutropenic complications in breast cancer patients treated with dose-dense paclitaxel: A 5-year experience from a safety net hospital.

2019

Racha Halawi
Kavi Patel
Ethan Tobias
Samira Syed
Nisha Unni
Hsiao Ching Li
Navid Sadeghi

6527Background: The NCCN guidelines recommend growth factor (G-CSF) support to reduce the risk of febrile neutropenia and maintain dose density in patients receiving dose dense chemotherapy. We ret...

Keywords:

Safety net
Breast cancer
Paclitaxel
Pathology
Internal medicine
Growth factor
Oncology
Medicine
in patient
Febrile neutropenia
Dose-dense chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations